Cargando…

Plasma Neutralization of the SARS-CoV-2 Omicron Variant

Detalles Bibliográficos
Autores principales:	Schmidt, Fabian, Muecksch, Frauke, Weisblum, Yiska, Da Silva, Justin, Bednarski, Eva, Cho, Alice, Wang, Zijun, Gaebler, Christian, Caskey, Marina, Nussenzweig, Michel C., Hatziioannou, Theodora, Bieniasz, Paul D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Massachusetts Medical Society 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757565/ https://www.ncbi.nlm.nih.gov/pubmed/35030645 http://dx.doi.org/10.1056/NEJMc2119641

Ejemplares similares

Plasma neutralization properties of the SARS-CoV-2 Omicron variant
por: Schmidt, Fabian, et al.
Publicado: (2021)

Severe Acute Respiratory Syndrome Coronavirus 2 Neutralization After Messenger RNA Vaccination and Variant Breakthrough Infection
por: Gaebler, Christian, et al.
Publicado: (2022)

SARS-CoV-2 spike glycosylation affects function and neutralization sensitivity
por: Zhang, Fengwen, et al.
Publicado: (2023)

Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses
por: Schmidt, Fabian, et al.
Publicado: (2020)

Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses
por: Schmidt, Fabian, et al.
Publicado: (2020)

Epistasis lowers the genetic barrier to SARS-CoV-2 neutralizing antibody escape
por: Witte, Leander, et al.
Publicado: (2022)

Epistasis lowers the genetic barrier to SARS-CoV-2 neutralizing antibody escape
por: Witte, Leander, et al.
Publicado: (2023)

Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants
por: Weisblum, Yiska, et al.
Publicado: (2020)

Mutational escape from the polyclonal antibody response to SARS-CoV-2 infection is largely shaped by a single class of antibodies
por: Greaney, Allison J., et al.
Publicado: (2021)

Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies
por: Greaney, Allison J., et al.
Publicado: (2021)

Antigen presentation dynamics shape the antibody response to variants like SARS-CoV-2 Omicron after multiple vaccinations with the original strain
por: Yang, Leerang, et al.
Publicado: (2023)

Antigen presentation dynamics shape the response to emergent variants like SARS-CoV-2 Omicron strain after multiple vaccinations with wild type strain
por: Yang, Leerang, et al.
Publicado: (2022)

Development of potency, breadth and resilience to viral escape mutations in SARS-CoV-2 neutralizing antibodies
por: Muecksch, Frauke, et al.
Publicado: (2021)

Absence of SARS-CoV-2 neutralizing activity in pre-pandemic sera from individuals with recent seasonal coronavirus infection
por: Poston, Daniel, et al.
Publicado: (2020)

Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations
por: Muecksch, Frauke, et al.
Publicado: (2021)

Absence of Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Activity in Prepandemic Sera From Individuals With Recent Seasonal Coronavirus Infection
por: Poston, Daniel, et al.
Publicado: (2020)

Memory B cell responses to Omicron subvariants after SARS-CoV-2 mRNA breakthrough infection in humans
por: Wang, Zijun, et al.
Publicado: (2022)

Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection
por: Wang, Zijun, et al.
Publicado: (2021)

Enhanced SARS-CoV-2 neutralization by dimeric IgA
por: Wang, Zijun, et al.
Publicado: (2021)

Enhanced SARS-CoV-2 Neutralization by Secretory IgA in vitro
por: Wang, Zijun, et al.
Publicado: (2020)

Conserved Neutralizing Epitopes on the N-Terminal Domain of Variant SARS-CoV-2 Spike Proteins
por: Wang, Zijun, et al.
Publicado: (2022)

Analysis of memory B cells identifies conserved neutralizing epitopes on the N-terminal domain of variant SARS-Cov-2 spike proteins
por: Wang, Zijun, et al.
Publicado: (2022)

Increased memory B cell potency and breadth after a SARS-CoV-2 mRNA boost
por: Muecksch, Frauke, et al.
Publicado: (2022)

Antibody evolution to SARS-CoV-2 after single-dose Ad26.COV2.S vaccine in humans
por: Cho, Alice, et al.
Publicado: (2022)

Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies
por: Barnes, Christopher O., et al.
Publicado: (2020)

Structures of human antibodies bound to SARS-CoV-2 spike reveal common epitopes and recurrent features of antibodies
por: Barnes, Christopher O., et al.
Publicado: (2020)

Antibody feedback regulation of memory B cell development in SARS-CoV-2 mRNA vaccination
por: Schaefer-Babajew, Dennis, et al.
Publicado: (2022)

Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID19 Patients
por: Luchsinger, Larry L., et al.
Publicado: (2020)

Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID-19 Patients
por: Luchsinger, Larry L., et al.
Publicado: (2020)

Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination
por: Cho, Alice, et al.
Publicado: (2021)

Antibody feedback regulates immune memory after SARS-CoV-2 mRNA vaccination
por: Schaefer-Babajew, Dennis, et al.
Publicado: (2022)

Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies
por: Jette, Claudia A., et al.
Publicado: (2021)

Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies
por: Jette, Claudia A., et al.
Publicado: (2021)

Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies
por: Jette, Claudia A., et al.
Publicado: (2021)

Vaccine Breakthrough Infections with SARS-CoV-2 Variants
por: Hacisuleyman, Ezgi, et al.
Publicado: (2021)

A Recombinant Protein SARS-CoV-2 Candidate Vaccine Elicits High-titer Neutralizing Antibodies in Macaques.
por: Baisa, Gary, et al.
Publicado: (2021)

“A recombinant protein SARS-CoV-2 candidate vaccine elicits high-titer neutralizing antibodies in macaques.”
por: Baisa, Gary, et al.
Publicado: (2020)

Humoral immunity to SARS-CoV-2 elicited by combination COVID-19 vaccination regimens
por: Wang, Zijun, et al.
Publicado: (2022)

VPS29 Exerts Opposing Effects on Endocytic Viral Entry
por: Poston, Daniel, et al.
Publicado: (2022)

Antibody potency, effector function and combinations in protection from SARS-CoV-2 infection in vivo
por: Schäfer, Alexandra, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_s4m7276pfs8k1oiiabup1t14dc